| Dr Yolette Louis, MD | |
|
3000 32nd Ave S, Fargo, ND 58103-6132 | |
| (701) 364-8000 | |
| Not Available |
| Full Name | Dr Yolette Louis |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 13 Years |
| Location | 3000 32nd Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225316318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 30632 (Oklahoma) | Secondary |
| 208M00000X | Hospitalist | 30632 (Oklahoma) | Secondary |
| 208M00000X | Hospitalist | 17201 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeastern Health System | Tahlequah, OK | Hospital |
| Mcalester Regional Health Center | Mcalester, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeastern Health System | 1456255025 | 95 |
| Prime Physician Staffing 2 Pllc | 7416292636 | 14 |
| Waterloo Park Inpatient Services Pllc | 4880820513 | 29 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
| Entity Name | Northeastern Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457574170 PECOS PAC ID: 1456255025 Enrollment ID: O20031125000250 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
| Entity Name | Mcalester Regional Health Center Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316940034 PECOS PAC ID: 6709796436 Enrollment ID: O20040303001042 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
| Entity Name | Mcalester Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317998 PECOS PAC ID: 9931139029 Enrollment ID: O20050818000234 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
| Entity Name | Prime Physician Staffing 2 Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427523109 PECOS PAC ID: 7416292636 Enrollment ID: O20181217001900 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yolette Louis, MD 1702 University Dr S, Fargo, ND 58103-4940 Ph: () - | Dr Yolette Louis, MD 3000 32nd Ave S, Fargo, ND 58103-6132 Ph: (701) 364-8000 |
News Archive
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.
Humans have an uncanny ability to skim through text, instantly recognizing words by their shape-even though writing developed only about 6000 years ago-long after humans evolved. Thus, neuroscientists have hotly debated whether an area of the cortex called the Visual Word Form Area (VWFA) is truly a specific and necessary area for recognizing words.
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images.
Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.
Echo Therapeutics, Inc., a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced financial results for the year ended December 31, 2013.
› Verified 1 days ago
Malik Muhammad Anwar Ul Haq, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 | |
Christina Harmon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 | |
Riley Clark, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2000 | |
Irina Hillman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 Fax: 701-417-2535 | |
Hannah Margaret Schradick, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-234-5933 | |
James D Fowler, PA Hospitalist Medicare: Medicare Enrolled Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 | |
Weimin Hao, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 737 Broadway, Fargo, ND 58122 Phone: 701-234-2731 Fax: 701-234-2158 |